Fullerton Fund Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$41.6M |
| 2 |
International Flavors & Fragrances
IFF
|
+$28.3M |
| 3 |
Idexx Laboratories
IDXX
|
+$28.2M |
| 4 |
iShares MSCI India ETF
INDA
|
+$28M |
| 5 |
Northrop Grumman
NOC
|
+$25.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$111M |
| 2 |
ConocoPhillips
COP
|
+$46.7M |
| 3 |
Caterpillar
CAT
|
+$44.3M |
| 4 |
NIO
NIO
|
+$36.5M |
| 5 |
Pinduoduo
PDD
|
+$36.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.82% |
| 2 | Healthcare | 12.81% |
| 3 | Technology | 12.51% |
| 4 | Communication Services | 8.18% |
| 5 | Financials | 6.93% |
Similar funds
Fullerton Fund Management's Q3 2022 Portfolio in Review
As of Q3 2022, Fullerton Fund Management held 79 positions worth $1.34B, down 11% from $1.51B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Fullerton Fund Management withdrew a net $73.5M in Q3 2022, closing 17 positions and reducing 18 holdings. Its most notable exit was Caterpillar, an estimated $44.3M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Fullerton Fund Management opened a new position in Eli Lilly worth $42.4M.
- Fullerton Fund Management's largest Q3 2022 buy was Eli Lilly: 131,279 shares worth $42.4M.
- Fullerton Fund Management added most to Northrop Grumman in Q3 2022, an estimated $25.8M increase.
- Fullerton Fund Management's biggest Q3 2022 reduction was SPDR Gold Trust, cutting an estimated $111M.
- Fullerton Fund Management fully exited Caterpillar in Q3 2022, selling an estimated $44.3M.
- Fullerton Fund Management's ten largest holdings make up 42% of its $1.34B portfolio in Q3 2022.
- Fullerton Fund Management opened 21 new positions and closed 17 in Q3 2022.
- Fullerton Fund Management's portfolio value fell 11% quarter-over-quarter to $1.34B.
Based on Fullerton Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.